This Month in JNM

You do not have access to the full text of this article, the first page of the PDF of this article appears above.

This article requires a subscription to view the full text. If you have a subscription you may use the login form below to view the article. Access to this article can also be purchased.

Individuals

Non-Member Login

In this issue

Download PDF

Article Alerts

Email Article

Citation Tools

Tau^IQ: A Canonical Image Based Algorithm to Quantify Tau PET Scans
Hypermetabolism on Pediatric PET Scans of Brain Glucose Metabolism: What Does It Signify?
Dual PET Imaging in Bronchial Neuroendocrine Neoplasms: The NETPET Score as a Prognostic Biomarker
Dopamine D₁ Receptor Agonist PET Tracer Development: Assessment in Nonhuman Primates
Anti-CEA Pretargeted Immuno-PET Shows Higher Sensitivity Than DOPA PET/CT in Detecting Relapsing Metastatic Medullary Thyroid Carcinoma: Post Hoc Analysis of the iPET-MTC Study
The Impact of Monosodium Glutamate on ⁶⁸Ga-PSMA-11 Biodistribution in Men with Prostate Cancer: A Prospective Randomized, Controlled Imaging Study
PSMA Theranostics: Is the Time Ripe to Pave the Way to Further Tumor Entities?
Combination of Forced Diuresis with Additional Late Imaging in ⁶⁸Ga-PSMA-11 PET/CT: Effects on Lesion Visibility and Radiotracer Uptake
Distinguishing Primary Lateral Sclerosis from Parkinsonian Syndromes with the Help of Advanced Imaging
Head-to-Head Comparison of ⁶⁸Ga-Prostate-Specific Membrane Antigen PET/CT and Ferumoxtran-10–Enhanced MRI for the Diagnosis of Lymph Node Metastases in Prostate Cancer Patients
Image-Guided High-Intensity Focused Ultrasound, A Novel Application for Interventional Nuclear Medicine?
Systemic Radiopharmaceutical Therapy of Pheochromocytoma and Paraganglioma
Optical Navigation of the Drop-In γ-Probe as a Means to Strengthen the Connection Between Robot-Assisted and Radioguided Surgery
Leadership Focus on Advancing Cancer Research and Treatment
Current Landscape in Clinical Pretargeted Radioimmunoimaging and Therapy
⁶⁸Ga-PSMA-11 PET/CT Improves Tumor Detection and Impacts Management in Patients with Hepatocellular Carcinoma
Synthesis and Preclinical Evaluation of a ⁶⁸Ga-Labeled Adnectin, ⁶⁸Ga-BMS-986192, as a PET Agent for Imaging PD-L1 Expression
Assessment and Comparison of ¹⁸F-Fluorocholine PET and ^99mTc-Sestamibi Scans in Identifying Parathyroid Adenomas: A Metaanalysis
Why Will PET Be the Future of Nuclear Cardiology?
SUVs Are Adequate Measures of Lesional ¹⁸F-DCFPyL Uptake in Patients with Low Prostate Cancer Disease Burden
Diversity, Equity, and Inclusion in Academic Nuclear Medicine: National Survey of Nuclear Medicine Residency Program Directors
Addition of ¹³¹I-MIBG to PRRT (⁹⁰Y-DOTATOC) for Personalized Treatment of Selected Patients with Neuroendocrine Tumors
Value of ¹⁸F-FES PET in Solving Clinical Dilemmas in Breast Cancer Patients: A Retrospective Study
Detection of Early Progression with ¹⁸F-DCFPyL PET/CT in Men with Metastatic Castration-Resistant Prostate Cancer Receiving Bipolar Androgen Therapy

Cited By...

No citing articles found.

Google Scholar

More in this TOC Section

Show more This Month in JNM

Main menu

User menu

Search

This Month in JNM

Individuals

In this issue

Citation Manager Formats

Related Articles

Cited By...

More in this TOC Section

Similar Articles

Main menu

User menu

Search

This Month in JNM

SNMMI members

Individuals

In this issue

Citation Manager Formats

Jump to section

Related Articles

Cited By...

More in this TOC Section

Similar Articles